Evoxac
NDC 0713-0883, cevimeline hydrochloride, capsule, from Cosette Pharmaceuticals, Inc..
- Product NDC
- 0713-0883
- Status
- Listed
- Labeler
- Cosette Pharmaceuticals, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020989
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0713-0883 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- CEVIMELINE HYDROCHLORIDE30 mg/1
Pharmacologic classes
Cholinergic Muscarinic Agonists [MoA]; Cholinergic Receptor Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0713-0883-01 | 00713088301 | 100 CAPSULE in 1 BOTTLE, PLASTIC (0713-0883-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/dac32a9b-05b8-42c2-9a29-d885a9279456NADAC price for package 00713088301
GET /v1/drugs/nadac/00713088301
Use it
Look up 0713-0883 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0713-0883 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0713-0883. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.